Table 1.
Postoperative Ultrasound Time Point | Stenosis Prevalence | Venous Blood Flow Rate | Mean Venous Diameter | ||||||
---|---|---|---|---|---|---|---|---|---|
ORa | 95% CI | P Valueb | Relative Δ, %c,d | 95% CI | P Valueb | Δ, mmc,e | 95% CI | P Valueb | |
6 wkf | 1.07 | 1.00 to 1.16 | 0.07 | −2.5 | −4.6 to −0.4 | 0.02 | −0.018 | −0.07 to 0.03 | 0.46 |
2 wk | 1.00 | 0.93 to 1.09 | 0.91 | −1.5 | −3.3 to 0.5 | 0.14 | −0.002 | −0.04 to 0.04 | 0.92 |
1 d | 1.04 | 0.94 to 1.16 | 0.49 | −0.2 | −1.9 to 1.5 | 0.81 | −0.001 | −0.03 to 0.03 | 0.94 |
All analyses involve multiply imputed data.
OR of developing stenosis per 10% increase in intimal hyperplasia index adjusted for age, sex, black race, chronic dialysis status at time of AVF creation, and AVF location (upper arm versus forearm) as well as inflow artery diameter, mean vein diameter, and brachial artery blood flow rate on preoperative ultrasound, with clinical center modeled as a random variable.
P≤0.05 is nominally considered to be statistically significant.
Adjusted for age, sex, black race, chronic dialysis status at time of AVF creation, and AVF location (upper arm versus forearm), with clinical center modeled as a random variable.
Percent relative change in AVF blood flow rate per 10% increase in intimal hyperplasia index.
Change in mean AVF vein diameter (millimeters) per 10% increase in intimal hyperplasia index.
Week 6 results were identified a priori as the primary ultrasound outcomes among the three time points. Hence, these P values were not corrected for testing at multiple time points.